Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002343591 | SCV002646255 | uncertain significance | Cardiovascular phenotype | 2020-08-25 | criteria provided, single submitter | clinical testing | The p.P178L variant (also known as c.533C>T), located in coding exon 3 of the TBX20 gene, results from a C to T substitution at nucleotide position 533. The proline at codon 178 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002477671 | SCV002787370 | uncertain significance | Atrial septal defect 4 | 2021-08-09 | criteria provided, single submitter | clinical testing | |
Centre of Medical Genetics, |
RCV000770950 | SCV000854412 | uncertain significance | Aortic valve disease 1 | 2018-11-14 | no assertion criteria provided | research |